When contacted, the FMGC firm, promoted by yoga guru Ramdev, said the amla juice is a medicinal product unlike other juices sold in the market and that it is absolutely safe for human consumption.
Defence ministry sources said a show cause notice has been served on the company after the juice "failed" the test. The test was carried out at West Bengal Public Health Laboratory, Kolkata.
The sources said as per procedure, CSD has immediately suspended the sale of the particular batch of the item and sent a show cause notice to the company to examine the deviations and explain about them.
The CSD had sent samples of 'Amla Juice' having index no. 85417 and batch No. GH1502 to the laboratory in Kolkata, they said.
The Patanjali Ayurveda said its amla juice is an ayurvedic medicine and test on it should be conducted as per the norms of the AYUSH ministry. The firm said norms prescribed by the country's food regulator--Food Safety and Standards Authority of India-- were not applicable to the juice.
The CSD regularly sends items from its inventory for testing at various government-run laboratories across the country.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
